Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Elke A, Jarboe"'
Autor:
Jeffery M. Vahrenkamp, Chieh-Hsiang Yang, Adriana C. Rodriguez, Aliyah Almomen, Kristofer C. Berrett, Alexis N. Trujillo, Katrin P. Guillen, Bryan E. Welm, Elke A. Jarboe, Margit M. Janat-Amsbury, Jason Gertz
Publikováno v:
Cell Reports, Vol 22, Iss 11, Pp 2995-3005 (2018)
Summary: Steroid hormone receptors are simultaneously active in many tissues and are capable of altering each other’s function. Estrogen receptor α (ER) and glucocorticoid receptor (GR) are expressed in the uterus, and their ligands have opposing
Externí odkaz:
https://doaj.org/article/373a73b79ed044d69306f26432b18e84
Autor:
Zuolian Shen, Jinsuk Kang, Arvind Shakya, Marcin Tabaka, Elke A Jarboe, Aviv Regev, Dean Tantin
Publikováno v:
eLife, Vol 6 (2017)
Embryonic stem cells co-express Oct4 and Oct1, a related protein with similar DNA-binding specificity. To study the role of Oct1 in ESC pluripotency and transcriptional control, we constructed germline and inducible-conditional Oct1-deficient ESC lin
Externí odkaz:
https://doaj.org/article/79473ceb904e4d3195794fd53eb69f4e
Autor:
Zannel Blanchard, Spencer Arnesen, Jeffery M. Vahrenkamp, Adriana C. Rodriguez, Elke A. Jarboe, Callie Brown, Katarzyna Modzelewska, David H. Lum, Jason Gertz
Activating estrogen receptor alpha (ER) mutations are present in primary endometrial and metastatic breast cancers, promoting estrogen-independent activation of the receptor. Functional characterizations in breast cancer have established unique molec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::902e72d462966d7748afb6e23f2e1021
https://doi.org/10.1101/2022.06.13.495977
https://doi.org/10.1101/2022.06.13.495977
Publikováno v:
International Journal of Gynecological Pathology. 40:470-476
Extraskeletal myxoid chondrosarcoma of the vulva is a very rare tumor, with less than 10 cases reported in the literature. We report a case of a 45-yr-old woman with extraskeletal myxoid chondrosarcoma of the vulva confirmed by EWSR1 fluorescence in
Publikováno v:
Journal of medical genetics.
BackgroundUptake of risk-reducing surgery has increased among women at high risk of epithelial ovarian cancer. We sought to characterise familial risk of epithelial ovarian cancer histotypes in a population-based study after accounting for gynaecolog
Publikováno v:
JCO Oncology Practice. 17:206-208
Autor:
Sungpil Cho, Hongsuk Park, Elke A Jarboe, C Matthew Peterson, You Han Bae, Margit M Janát-Amsbury
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141172 (2015)
Cancer stem cells (CSCs) are a small subset of cancer cells responsible for maintenance and progression of several types of cancer. Isolation, propagation, and the differentiation of CSCs in the proper stem niches expose the intrinsic difficulties fo
Externí odkaz:
https://doaj.org/article/427b683983404797b6740707f21f4503
Autor:
Elke A. Jarboe, Kathryn Szczotka, Mark K. Dodson, Jeffery M. Vahrenkamp, Jason Gertz, Andrew P. Soisson
Publikováno v:
Genome Research. 29:1826-1835
The majority of clinical cancer specimens are preserved as formalin-fixed paraffin-embedded (FFPE) samples. For clinical molecular tests to have wide-reaching impact, they must be applicable to FFPE material. Accurate quantitative measurements of RNA
Autor:
Charles M. Quick, John F. DeCoteau, Nick Baniak, Mary Kinloch, Vinita Parkash, Jonathan L. Hecht, Sharon X. Liang, Oluwole Fadare, Elke A. Jarboe, Martin Köbel, Krisztina Z. Hanley, Wenxin Zheng, Katja Gwin
Publikováno v:
American Journal of Surgical Pathology. 43:531-537
Endometrial clear cell carcinoma (ECCC) is an uncommon histotype without unique identified molecular alterations. Recently, The Cancer Genome Atlas molecular subtypes have been reported in ECCC. ECCC cases were collected from 11 institutions with dia
Autor:
Mollie E. Barnard, Robert Sargent, G. Bryce Christensen, Bonita A. Mahaffey, James Albro, Elke A. Jarboe, Terence Rhodes, Nicola J. Camp, Jennifer A. Doherty
Publikováno v:
Cancer Research. 82:30-30
Introduction: Genetic risk variants are critical to risk prediction for invasive epithelial ovarian cancer (EOC), yet an estimated 50-55% of EOC heritability remains missing. Novel approaches to risk variant discovery are needed to detect variants th